Inicia sesión Registrate Mi Biblioteca idioma

Idioma

biblioteca idioma abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará la selección de artículos sobre Trastornos del Movimiento clasificados según los 11 tipos establecidos por International Parkinson & Movement Disorder Society.

Enfermedad de Parkinson

8289 ARTíCULOS , VIENDO DEL 7021 AL 7035

PUBMED

Neuroprotective effects of Bacopa monnieri in Parkinson's disease model

Singh B, Pandey S, Rumman M, Mahdi AA.

Metab Brain Dis. 2020 Mar;35(3):517-525. doi: 10.1007/s11011-019-00526-w. Epub 2019 Dec 13.

0

0

0

PUBMED

Salivary microR-153 and microR-223 Levels as Potential Diagnostic Biomarkers of Idiopathic Parkinson's Disease

Cressatti M, Juwara L, Galindez JM, Velly AM, Nkurunziza ES, Marier S, Canie O, Gornistky M, Schipper HM.

Mov Disord. 2020 Mar;35(3):468-477. doi: 10.1002/mds.27935. Epub 2019 Dec 4.

0

0

0

PUBMED

NF-κB-Mediated Neuroinflammation in Parkinson's Disease and Potential Therapeutic Effect of Polyphenols

Singh SS, Rai SN, Birla H, Zahra W, Rathore AS, Singh SP.

Neurotox Res. 2020 Mar;37(3):491-507. doi: 10.1007/s12640-019-00147-2. Epub 2019 Dec 10.

0

0

0

PUBMED

Circulating Brain-enriched MicroRNAs for detection and discrimination of idiopathic and genetic Parkinson's disease

Ravanidis S, Bougea A, Papagiannakis N, Maniati M, Koros C, Simitsi AM, Bozi M, Pachi I, Stamelou M, Paraskevas GP, Kapaki E, Moraitou M, Michelakakis H, Stefanis L, Doxakis E.

Mov Disord. 2020 Mar;35(3):457-467. doi: 10.1002/mds.27928. Epub 2019 Dec 4.

0

0

0

PUBMED

Characterization of novel conformation-selective α-synuclein antibodies as potential immunotherapeutic agents for Parkinson's disease

Henderson MX, Covell DJ, Chung CH, Pitkin RM, Sandler RM, Decker SC, Riddle DM, Zhang B, Gathagan RJ, James MJ, Trojanowski JQ, Brunden KR, Lee VMY, Luk KC.

Neurobiol Dis. 2020 Mar;136:104712. doi: 10.1016/j.nbd.2019.104712. Epub 2019 Dec 16.

0

0

0

PUBMED

The role of virtual reality on outcomes in rehabilitation of Parkinson's disease: meta-analysis and systematic review in 1031 participants

Triegaardt J, Han TS, Sada C, Sharma S, Sharma P.

Neurol Sci. 2020 Mar;41(3):529-536. doi: 10.1007/s10072-019-04144-3. Epub 2019 Dec 6.

0

0

0

PUBMED

Association of genetic variants within HLA-DR region with Parkinson's disease in Taiwan

Chang KH, Wu YR, Chen YC, Fung HC, Chen CM.

Neurobiol Aging. 2020 Mar;87:140.e13-140.e18. doi: 10.1016/j.neurobiolaging.2019.11.002. Epub 2019 Nov 9.

0

0

0

PUBMED

Alterations of regional homogeneity in Parkinson's disease with mild cognitive impairment: a preliminary resting-state fMRI study

Li MG, Liu TF, Zhang TH, Chen ZY, Nie BB, Lou X, Wang ZF, Ma L.

Neuroradiology. 2020 Mar;62(3):327-334. doi: 10.1007/s00234-019-02333-7. Epub 2019 Dec 10.

0

0

0

PUBMED

Frequency of non-motor symptoms and their impact on the quality of life in patients with Parkinson's disease: a prospective descriptive case series

Gulunay A, Cakmakli GY, Yon MI, Ulusoy EK, Karakoc M.

Psychogeriatrics. 2020 Mar;20(2):206-211. doi: 10.1111/psyg.12489. Epub 2019 Nov 28.

0

0

0

PUBMED

Improvement of oral function and hygiene in Parkinson's disease: A randomised controlled clinical trial

Baram S, Karlsborg M, Bakke M.

J Oral Rehabil. 2020 Mar;47(3):370-376. doi: 10.1111/joor.12924. Epub 2020 Jan 5.

0

0

0

PUBMED

No genetic evidence for involvement of alcohol dehydrogenase genes in risk for Parkinson's disease

Kim JJ, Bandres-Ciga S, Blauwendraat C; International Parkinson's Disease Genomics Consortium, Gan-Or Z.

Neurobiol Aging. 2020 Mar;87:140.e19-140.e22. doi: 10.1016/j.neurobiolaging.2019.11.006. Epub 2019 Nov 14.

0

0

0

PUBMED

Utilization Patterns of Amantadine in Parkinson's Disease Patients Enrolled in the French COPARK Study.

Rascol O, Negre-Pages L, Damier P, Delval A, Derkinderen P, Destée A, Fabbri M, Meissner WG, Rachdi A, Tison F, Perez-Lloret S; COPARK Study Group..

Drugs Aging. 2020 Mar;37(3):215-223. doi: 10.1007/s40266-019-00740-2.

0

0

0

PUBMED

What predicts quality of life after subthalamic deep brain stimulation in Parkinson's disease? A systematic review

Geraedts VJ, Feleus S, Marinus J, van Hilten JJ, Contarino MF.

Eur J Neurol. 2020 Mar;27(3):419-428. doi: 10.1111/ene.14147. Epub 2020 Jan 24.

0

0

0

PUBMED

Differences in cognitive profiles between Lewy body and Parkinson's disease dementia.

Martini A, Weis L, Schifano R, Pistonesi F, Fiorenzato E, Antonini A, Biundo R.

J Neural Transm (Vienna). 2020 Mar;127(3):323-330. doi: 10.1007/s00702-019-02129-2. Epub 2020 Jan 2.

0

0

0

PUBMED

Alterations of the gut microbiota with antibiotics protects dopamine neuron loss and improve motor deficits in a pharmacological rodent model of Parkinson's disease

Koutzoumis DN, Vergara M, Pino J, Buddendorff J, Khoshbouei H, Mandel RJ, Torres GE.

Exp Neurol. 2020 Mar;325:113159. doi: 10.1016/j.expneurol.2019.113159. Epub 2019 Dec 13.

0

0

0

Comentarios

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo HONcode Logo WIS

En colaboración con:

Zambon Neuroacademy